The scientist’s investigation covers issues in Prostate cancer, Prostatectomy, Prostate, Surgery and Urology. Hartwig Huland combines subjects such as Biopsy and Pathology with his study of Prostate cancer. His Prostatectomy research includes elements of Neurovascular bundle and Retrospective cohort study.
His Prostate research incorporates themes from Survival rate and Lymph node. In his work, Logistic regression, Prostate biopsy and Cohort is strongly intertwined with Nomogram, which is a subfield of Surgery. His Urology research is multidisciplinary, incorporating perspectives in Urinary continence, Predictive value of tests, Gynecology, Proportional hazards model and Stage.
Hartwig Huland focuses on Prostate cancer, Prostatectomy, Urology, Internal medicine and Prostate. The various areas that he examines in his Prostate cancer study include Cancer research and Biopsy. His work investigates the relationship between Prostatectomy and topics such as Surgery that intersect with problems in Nomogram and Radical retropubic prostatectomy.
His Urology research incorporates themes from Logistic regression, Positive Surgical Margin, Urinary system, Gynecology and Cohort. Internal medicine connects with themes related to Oncology in his study. His Prostate study incorporates themes from Tissue microarray and Pathology.
Hartwig Huland spends much of his time researching Prostate cancer, Prostatectomy, Internal medicine, Biochemical recurrence and Urology. His study in Prostate cancer is interdisciplinary in nature, drawing from both Cancer research, Prostate and Tissue microarray. His Prostatectomy research integrates issues from Logistic regression, Proportional hazards model, Surgery, Lymph node and Biopsy.
Cohort, Prostate-specific antigen and Confidence interval is closely connected to Oncology in his research, which is encompassed under the umbrella topic of Internal medicine. His Biochemical recurrence study combines topics in areas such as Adjuvant and Metastasis. Many of his research projects under Urology are closely connected to In patient with In patient, tying the diverse disciplines of science together.
Hartwig Huland focuses on Prostate cancer, Prostatectomy, Internal medicine, Urology and Biochemical recurrence. The Prostate cancer study combines topics in areas such as Logistic regression, Prostate and Tissue microarray. Hartwig Huland combines subjects such as Stage, Proportional hazards model, Surgery, Lymph node and Nomogram with his study of Prostatectomy.
His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Metastasis and Propensity score matching. Hartwig Huland usually deals with Urology and limits it to topics linked to Hazard ratio and Salvage therapy, Interquartile range, Risk of mortality and Mortality rate. His Biochemical recurrence study integrates concerns from other disciplines, such as Immunohistochemistry and Salvage radiation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
Alexander Haese;Alexandre de la Taille;Hendrik van Poppel;Michael Marberger.
European Urology (2008)
A PREOPERATIVE NOMOGRAM IDENTIFYING DECREASED RISK OF POSITIVE PELVIC LYMPH NODES IN PATIENTS WITH PROSTATE CANCER
Ilias Cagiannos;Pierre Karakiewicz;James A. Eastham;Makato Ohori.
The Journal of Urology (2003)
Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors
Michael W. Kattan;James A. Eastham;Thomas M. Wheeler;Norio Maru.
The Journal of Urology (2003)
Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
Lars Budäus;Sami-Ramzi Leyh-Bannurah;Georg Salomon;Uwe Michl.
European Urology (2016)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt;Ronald Simon;Lars Feuerbach;Karin Schlangen.
Cancer Cell (2013)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
EVALUATION OF PROSTATE CANCER DETECTION WITH REAL- TIME-ELASTOGRAPHY: A COMPARISON WITH STEP SECTION PATHOLOGICAL ANALYSIS AFTER RADICAL PROSTATECTOMY
G. Salomon;J. Köllermann;I. Thederan;T. Schlomm.
European Urology Supplements (2008)
High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series
Jochen Walz;Markus Graefen;Felix K.-H. Chun;Andreas Erbersdobler.
European Urology (2006)
Urodynamic Evaluation of Changes in Urinary Control After Radical Retropubic Prostatectomy
P. Hammerer;H. Huland.
The Journal of Urology (1997)
CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
Lia Burkhardt;Sarah Fuchs;Antje Krohn;Sawinee Masser.
Cancer Research (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: